Search results for "Administration"

showing 10 items of 5106 documents

The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study.

2013

Background. Growing evidence indicates that vitamin D receptor activation may have antiproteinuric effects. We aimed to evaluate whether vitamin D supplementation with daily cholecalciferol could reduce albuminuria in proteinuric chronic kidney disease (CKD) patients. Methods. This 6-month prospective, controlled, intervention study enrolled 101 non-dialysis CKD patients with albuminuria. Patients with low 25(OH) vitamin D [25(OH)D] and high parathyroid hormone (PTH) levels (n = 50; 49%) received oral cholecalciferol (666 IU/day), whereas those without hyperparathyroidism (n = 51; 51%), independent of their vitamin D status, did not receive any cholecalciferol, and were considered as the co…

AdultMalemedicine.medical_specialtyUrologyRenal functionParathyroid hormoneAdministration OralCalcitriol receptorPhosphateschemistry.chemical_compoundYoung AdultChronic kidney diseaseEstadística e Investigación OperativaInternal medicinemedicineVitamin D and neurologyAlbuminuriaHumansProspective StudiesRenal Insufficiency ChronicVitamin DAgedCholecalciferolAged 80 and overTransplantationHyperparathyroidismbusiness.industryHyperparathyroidismVitaminsMiddle Agedmedicine.diseaseVitamin D DeficiencyEndocrinologychemistryNephrologyParathyroid HormoneDietary SupplementsAlbuminuriaDisease ProgressionFemalemedicine.symptomCholecalciferolbusinessKidney diseaseNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
researchProduct

Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: the extended DACUS study.

2011

Abstract The safest duration of anticoagulation after idiopathic deep vein thrombosis (DVT) is unknown. We conducted a prospective study to assess the optimal duration of vitamin K antagonist (VKA) therapy considering the risk of recurrence of thrombosis according to residual vein thrombosis (RVT). Patients with a first unprovoked DVT were evaluated for the presence of RVT after 3 months of VKA administration; those without RVT suspended VKA, while those with RVT continued oral anticoagulation for up to 2 years. Recurrent thrombosis and/or bleeding events were recorded during treatment (RVT group) and 1 year after VKA withdrawal (both groups). Among 409 patients evaluated for unprovoked DVT…

AdultMalemedicine.medical_specialtyVitamin Kmedicine.drug_classDeep veinHemorrhageDrug Administration ScheduleSettore MED/15 - Malattie Del SangueRecurrenceRisk Factorsdeep vein thrombosis (DVT)Residual vein thrombosismedicineHumansProspective Studiesdeep vein thrombosis (DVT); vitamin K antagonist (VKA) therapy; Residual vein thrombosisProspective cohort studyAgedUltrasonographyVenous Thrombosisbusiness.industryAcenocoumarolAnticoagulantsHematologyVenous ThromboembolismVitamin K antagonistMiddle Agedmedicine.diseaseThrombosisConfidence intervalSurgeryClinical trialVein thrombosisvitamin K antagonist (VKA) therapymedicine.anatomical_structureLower ExtremityRelative riskFemaleWarfarinbusiness
researchProduct

Is it necessary to alter anticoagulation therapy for tooth extraction in patients taking direct oral anticoagulants?

2017

Background The number of patients using direct oral anticoagulants (DOACs) instead of vitamin K antagonists (VKA) is increasing and there is limited data on the safety of tooth extractions in patients taking DOACs. The aim of this study was to compare the amount of bleeding (AOB) and postoperative complications after tooth extractions between patients taking VKAs and patients taking DOACs without altering the anticoaguation therapy. Material and Methods The study consisted of four groups: Direct thrombin inhibitor group, factor Xa inhibitor group, warfarin group and a control group. A single tooth was extracted in each patient and routine coagulation test values were recorded prior to extra…

AdultMalemedicine.medical_specialtyVitamin Kmedicine.drug_mechanism_of_actionFactor Xa InhibitorAdministration OralPostoperative Hemorrhage030204 cardiovascular system & hematologyDirect oral anticoagulants03 medical and health sciencesPostoperative Complications0302 clinical medicineRivaroxabanChi-square testmedicineHumansApixabanProspective StudiesProspective cohort studyGeneral DentistryAgedAged 80 and overbusiness.industryResearchWarfarinAnticoagulants030206 dentistryMiddle Aged:CIENCIAS MÉDICAS [UNESCO]DabigatranSurgeryRegimenOtorhinolaryngologyCoagulationDirect thrombin inhibitorUNESCO::CIENCIAS MÉDICASTooth ExtractionFemaleSurgeryAnalysis of varianceOral Surgerybusinessmedicine.drugMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Effects of acute exercise and xanthine oxidase inhibition on novel cardiovascular biomarkers.

2013

Several sports have been associated with a postexercise increase of cardiac, liver, and skeletal muscle biomarkers of injury. Exhaustive or acute physical exercise causes an increased generation of reactive oxygen species, resulting in cellular injury. Thus, exercise and training may trigger pathophysiological changes in serum concentrations of a variety of biomarkers. In this study, we aimed to evaluate the variation of novel biomarkers of stress and cardiovascular disease such as copeptin, midregional part of proadrenomedullin (MR-proADM), growth differentiation factor 15 (GDF15), soluble vascular endothelial growth factor receptor, and placental growth factor along with uric acid before …

AdultMalemedicine.medical_specialtyXanthine OxidaseGrowth Differentiation Factor 15AllopurinolAllopurinolAdministration OralPhysical exercisePregnancy ProteinsPlacebochemistry.chemical_compoundAdrenomedullinCopeptinDouble-Blind MethodPhysiology (medical)Internal medicineSoccermedicineHumansEnzyme InhibitorsProtein PrecursorsXanthine oxidasesports; reactive oxygen species; allopurinolExercisePlacenta Growth Factorreactive oxygen speciesVascular Endothelial Growth Factor Receptor-1business.industryMyocardiumBiochemistry (medical)Public Health Environmental and Occupational HealthGlycopeptidesGeneral MedicinePeptide FragmentsUric AcidVascular endothelial growth factorEndocrinologychemistryAthletesUric acidGDF15sportsbusinessBiomarkersmedicine.drugTranslational research : the journal of laboratory and clinical medicine
researchProduct

A decision tree to help determine the best timing and antiretroviral strategy in HIV-infected patients.

2011

SUMMARYOptimal antiretroviral strategies for HIV-infected patients still need to be established. To this end a decision tree including different antiretroviral strategies that could be adopted for HIV-infected patients was built. A 10-year follow-up was simulated by using transitional probabilities estimated from a large cohort using a time-homogeneous Markov model. The desired outcome was for patients to maintain a CD4 cell count of >500 cells/mm3without experiencing AIDS or death. For patients with a baseline HIV viral load ⩾5 log10copies/ml, boosted protease inhibitor-based immediate highly active antiretroviral therapy (HAART) allowed them to spend 12% more time with CD4 ⩾500/mm3than…

AdultMalemedicine.medical_specialty[ INFO ] Computer Science [cs]EpidemiologyAnti-HIV AgentsDecision treeHIV InfectionsDrug Administration ScheduleCohort Studies03 medical and health sciences0302 clinical medicineLife ExpectancyAcquired immunodeficiency syndrome (AIDS)Internal medicineAntiretroviral Therapy Highly ActiveHiv infected patientsMedicineHumansProtease inhibitor (pharmacology)In patient[INFO]Computer Science [cs]Computer Simulation030212 general & internal medicineCd4 cell countComputingMilieux_MISCELLANEOUS0303 health sciences030306 microbiologybusiness.industryDecision TreesMiddle AgedViral Loadmedicine.diseaseAntiretroviral therapyMarkov Chains3. Good healthCD4 Lymphocyte CountInfectious DiseasesTreatment OutcomeImmunologyDisease ProgressionFemalebusinessViral loadFollow-Up StudiesEpidemiology and infection
researchProduct

Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation base…

2008

Abstract Residual vein thrombosis (RVT) indicates a prothrombotic state and is useful for evaluating the optimal duration of oral anticoagulant treatment (OAT). Patients with a first episode of deep vein thrombosis, treated with OAT for 3 months, were managed according to RVT findings. Those with RVT were randomized to either stop or continue anticoagulants for 9 additional months, whereas in those without RVT, OAT was stopped. Outcomes were recurrent venous thromboembolism and/or major bleeding. Residual thrombosis was detected in 180 (69.8%) of 258 patients; recurrent events occurred in 27.2% of those who discontinued (25/92; 15.2% person-years) and 19.3% of those who continued OAT (17/88…

AdultMalemedicine.medical_specialtymedicine.drug_classDeep veinImmunologyHemorrhageBiochemistryDrug Administration ScheduleSettore MED/15 - Malattie Del SangueDeep vein thrombosioral anticoagulantSecondary PreventionmedicineHumansAgedUltrasonographyVenous ThrombosisFirst episoderesidual vein thrombosisVascular diseasebusiness.industryAnticoagulantHazard ratioAnticoagulantsCell BiologyHematologyMiddle Agedmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareThrombosisConfidence intervalSurgeryVenous thrombosisTreatment Outcomemedicine.anatomical_structureFemalebusinessBlood
researchProduct

Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients

2005

Outpatient treatment of deep vein thrombosis (DVT) has become a common practice in uncomplicated patients. Few data are still present in patients with comorbidity (such as cancer) or concomitant symptomatic pulmonary embolism. Cancer patients with DVT are often excluded from home treatment because they have a higher risk of both bleeding and recurrent DVT. We tested the feasibility and safety of the Home Treatment (HT) program for acute DVT a PE in cancer patients. Patients were treated as outpatients unless they required admission for other medical problems, were actively bleeding or had pain that requires parenteral narcotics. Outpatient treatment was with low molecular weight heparin (LM…

AdultMalemedicine.medical_specialtymedicine.drug_classHome NursingDeep veinLow molecular weight heparinSelf Administration.Patient Education as TopicRecurrenceNeoplasmsmedicineHumansAgedAged 80 and overVenous Thrombosisbusiness.industryWarfarinCancerHematologyHeparin Low-Molecular-WeightMiddle Agedmedicine.diseaseThrombosisComorbidityHome Care ServicesPulmonary embolismSurgeryHospitalizationVenous thrombosismedicine.anatomical_structureOncologyFeasibility StudiesPatient ComplianceFemaleWarfarinbusinessPulmonary Embolismmedicine.drugFollow-Up Studies
researchProduct

Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain.

2005

Patients who experience a poor response to different systemic opioid trials (oral and intravenous) are candidates for spinal treatment. Breakthrough pain occurring in this group of patients is challenging for physicians. This phenomenon has never been described in this context and the treatment is quite difficult, as patients already demonstrated a poor response to systemic opioids. We report a preliminary experience of alternative methods, including the intrathecal injection of local anesthetic boluses as needed, or alternatively, the use of sublingual ketamine. Twelve consecutive patients with advanced cancer and pain were selected for intrathecal treatment after receiving different trial…

AdultMalemedicine.medical_specialtymedicine.drug_classPopulationAnalgesicAdministration SublingualPainNeoplasmsmedicineHumansKetamineAnesthetics LocaleducationGeneral NursingInjections SpinalAgedLevobupivacaineeducation.field_of_studyAnalgesicsbusiness.industryLocal anestheticMiddle AgedBupivacaineSurgeryAnesthesiology and Pain MedicineLevobupivacaineOpioidAnesthesiaMorphineFemaleKetamineNeurology (clinical)businessCancer painmedicine.drugJournal of pain and symptom management
researchProduct

Monitoring prothrombin fragment 1+2 during initiation of oral anticoagulant therapy after intracoronary stenting

1992

Patients with intracoronary stent implantation are treated with aggressive anticoagulant and antiplatelet therapy consisting of high-dose heparin, phenprocoumon, acetylsalicylic acid, dipyridamole, and the infusion of dextran to prevent a subacute thrombotic occlusion of the stented segment. In an effort to optimize this treatment by reducing both imminent bleeding complications and subacute thrombotic occlusion, the concentrations of prothrombin fragment 1 + 2 (F 1 + 2) were determined after intracoronary Palmaz-Schatz stent implantation in 19 consecutive patients. The F 1 + 2 concentrations after stent implantation and before the initiation of oral anticoagulant therapy (OAT) were 0.35 nm…

AdultMalemedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentUrologyAdministration OralPhenprocoumonmedicineHumansAngioplasty Balloon CoronaryAgedChemotherapyHeparinbusiness.industryPROTHROMBIN FRAGMENT 1.2AnticoagulantAnticoagulantsHematologyGeneral MedicineHeparinMiddle AgedThrombophlebitismedicine.diseaseThrombosisPeptide FragmentsDipyridamoleHeart Valve ProsthesisAnesthesiaPhenprocoumonFemaleProthrombinStentsPulmonary EmbolismComplicationbusinessmedicine.drugAnnals of Hematology
researchProduct

Forty-slice MDCT enteroclysis: evaluation after oral administration of isotonic solution in Crohn's disease.

2007

Objective. The aim of this study was to evaluate the accuracy of multidetector computed tomography (MDCT) enteroclysis after oral hyperhydration with isotonic solution in detecting bowel wall alterations in patients with Crohn’s disease. Materials and methods. Twenty-eight patients with a diagnosis of Crohn’s disease established by ileocolonoscopy and histology were enrolled in the study; 15 patients with negative ileocolonoscopy served as controls. In all cases, MDCT enteroclysis was performed after oral administration of 2,000 ml of isotonic solution and intravenous administration of N-butylscopolamine. Axial, isotropic multiplanar and volume-rendered reconstructions were used to evaluate…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentAdministration OralContrast MediaIntestino tenueSensitivity and SpecificityPolyethylene GlycolsCrohn DiseaseOral administrationPatologie gastrointestinaliIntestine SmallMedicineIntubationHumansRadiology Nuclear Medicine and imagingNeuroradiologyTC multidetettoreCrohn's diseasemedicine.diagnostic_testbusiness.industryCatharticsMultidetector CTUltrasoundInterventional radiologyGeneral MedicineEnemamedicine.diseaseGastrointestinal diseaseSmall boweldigestive system diseasesSpiral computed tomographyIopamidolFemaleRadiologyIsotonic SolutionsbusinessTomography X-Ray ComputedLa Radiologia medica
researchProduct